Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part I.
CNS Neurol Disord Drug Targets. 2009 Mar;8(1):1-6. doi: 10.2174/187152709787601849.
CNS Neurol Disord Drug Targets. 2009.
PMID: 19275632
No abstract available.